BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 16498256)

  • 1. Hepatic encephalopathy: from pathophysiology to treatment.
    Mas A
    Digestion; 2006; 73 Suppl 1():86-93. PubMed ID: 16498256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ammonia and GABA-ergic neurotransmission in pathogenesis of hepatic encephalopathy].
    Helewski K; Kowalczyk-Ziomek G; Konecki J
    Wiad Lek; 2003; 56(11-12):560-3. PubMed ID: 15058165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic encephalopathy: from pathophysiology to therapeutic management.
    Bismuth M; Funakoshi N; Cadranel JF; Blanc P
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):8-22. PubMed ID: 21099434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic encephalopathy.
    Munoz SJ
    Med Clin North Am; 2008 Jul; 92(4):795-812, viii. PubMed ID: 18570943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management.
    Gerber T; Schomerus H
    Drugs; 2000 Dec; 60(6):1353-70. PubMed ID: 11152016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hepatic encephalopathy in patients with cirrhosis.
    Wright G; Jalan R
    Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic encephalopathy: pathophysiology and emerging therapies.
    Sundaram V; Shaikh OS
    Med Clin North Am; 2009 Jul; 93(4):819-36, vii. PubMed ID: 19577116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic encephalopathy: a critical current review.
    Hadjihambi A; Arias N; Sheikh M; Jalan R
    Hepatol Int; 2018 Feb; 12(Suppl 1):135-147. PubMed ID: 28770516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current theories on the pathogenesis of hepatic encephalopathy.
    Mousseau DD; Butterworth RF
    Proc Soc Exp Biol Med; 1994 Sep; 206(4):329-44. PubMed ID: 7915420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent insights into the pathogenesis of hepatic encephalopathy and treatments.
    Sturgeon JP; Shawcross DL
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):83-100. PubMed ID: 24236755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible hepatic decerebration: a case report and review of the literature.
    Wehbe E; Saad D; Delgado F; Ta H; Antoun SA
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):759-60. PubMed ID: 19521243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatic encephalopathy in patients with cirrhosis: new aspects and practical recommendations].
    Ditisheim S; Spahr L
    Rev Med Suisse; 2010 Sep; 6(261):1667-71. PubMed ID: 20939401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hepatic encephalopathy: role of rifaximin.
    Zeneroli ML; Avallone R; Corsi L; Venturini I; Baraldi C; Baraldi M
    Chemotherapy; 2005; 51 Suppl 1():90-5. PubMed ID: 15855752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations on the impact of hepatic encephalopathy treatments in the pretransplant setting.
    Teperman LW; Peyregne VP
    Transplantation; 2010 Apr; 89(7):771-8. PubMed ID: 20110852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theories of the pathogenesis of hepatic encephalopathy.
    Jones EA; Mullen KD
    Clin Liver Dis; 2012 Feb; 16(1):7-26. PubMed ID: 22321462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular aspects of hepatic encephalopathy].
    Márquez-Aguirre AL; Canales-Aguirre AA; Gómez-Pinedo U; Gálvez-Gastélum FJ
    Neurologia; 2010 May; 25(4):239-47. PubMed ID: 20609302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic encephalopathy: pathophysiology and advances in therapy.
    Av SP
    Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome.
    Albrecht J; Jones EA
    J Neurol Sci; 1999 Nov; 170(2):138-46. PubMed ID: 10617392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatic encephalopathy].
    Hilgard P; Gerken G
    Med Klin (Munich); 2004 Oct; 99(10):591-602. PubMed ID: 15490075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.